- Home
- OPP vs TNYA Comparison
OPP vs TNYA Comparison
Compare OPP & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPP
- TNYA
- Stock Information
- Founded
- OPP 2010
- TNYA 2016
- Country
- OPP United States
- TNYA United States
- Employees
- OPP N/A
- TNYA N/A
- Industry
- OPP Finance/Investors Services
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- OPP Finance
- TNYA Health Care
- Exchange
- OPP Nasdaq
- TNYA Nasdaq
- Market Cap
- OPP 208.6M
- TNYA 189.1M
- IPO Year
- OPP N/A
- TNYA 2021
- Fundamental
- Price
- OPP $8.78
- TNYA $1.20
- Analyst Decision
- OPP
- TNYA Strong Buy
- Analyst Count
- OPP 0
- TNYA 5
- Target Price
- OPP N/A
- TNYA $8.60
- AVG Volume (30 Days)
- OPP 108.0K
- TNYA 4.6M
- Earning Date
- OPP 01-01-0001
- TNYA 11-05-2025
- Dividend Yield
- OPP 14.41%
- TNYA N/A
- EPS Growth
- OPP N/A
- TNYA N/A
- EPS
- OPP N/A
- TNYA N/A
- Revenue
- OPP N/A
- TNYA N/A
- Revenue This Year
- OPP N/A
- TNYA N/A
- Revenue Next Year
- OPP N/A
- TNYA N/A
- P/E Ratio
- OPP N/A
- TNYA N/A
- Revenue Growth
- OPP N/A
- TNYA N/A
- 52 Week Low
- OPP $7.26
- TNYA $0.36
- 52 Week High
- OPP $8.83
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- OPP 66.05
- TNYA 56.61
- Support Level
- OPP $8.70
- TNYA $1.25
- Resistance Level
- OPP $8.78
- TNYA $1.43
- Average True Range (ATR)
- OPP 0.07
- TNYA 0.10
- MACD
- OPP 0.01
- TNYA -0.01
- Stochastic Oscillator
- OPP 87.32
- TNYA 39.47
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.